X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Frontiers in Immunology

期刊標題檢索 FRONT IMMUNOL 最新評論: Why is the proportion of Chinese people so high in this publication?! (2024-06-17)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Frontiers in Immunology]您好,您是該頁面的第 457835 位訪客。

期刊簡介
期刊名稱Frontiers in Immunology Frontiers in Immunology
LetPub Score
7.9
51 ratings
Rate

Reputation
7.8

Influence
7.3

Speed
8.5

期刊簡稱FRONT IMMUNOL
ISSN1664-3224
h-index84
CiteScore
CiteScoreSJRSNIPCiteScore Rank
9.801.8681.193
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Immunology and Allergy
Q152 / 233
Category: Medicine
Subcategory: Immunology
Q158 / 236

自引率 (2023-2024)8.80%自引率趨勢
掲載範囲
Frontiers in Immunology is a leading journal in its field, publishing rigorously peer-reviewed research across basic, translational and clinical immunology. Field Chief Editor Luigi Daniele Notarangelo is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.

Frontiers in Immunology is the official Journal of the International Union of Immunological Societies (IUIS). Encompassing the entire field of Immunology, this journal welcomes papers that investigate basic mechanisms of immune system development and function, with a particular emphasis given to the description of the clinical and immunological phenotype of human immune disorders, and on the definition of their molecular basis.
官方網站http://journal.frontiersin.org/journal/immunology
在線稿件提交http://www.frontiersin.org/submission/submissioninfo.aspx
開放訪問Yes
出版商Frontiers Media S.A.
主題領域IMMUNOLOGY
出版國/地區SWITZERLAND
發行頻率
創刊年0
每年文章數5971每年文章數趨勢
黃金OA百分比99.67%
OA Related Info
APC: Yes( USD3295; )
APC waiver:Check Notes
Other charges: No
Keywords: immunology、adaptive immunity、innate immunity、clinical immunology、molecular immunology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
IMMUNOLOGYSCIEQ138/181
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1664-3224%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 14 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Frontiers in Immunology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE640686
    BIOMATERIALS569254
    BIOMEDICINE & PHARMACOTHERAPY498319
    Frontiers in Pharmacology486582
    Journal of Materials Chemistry B476053
    JOURNAL OF ETHNOPHARMACOLOGY475392
    COLLOIDS AND SURFACES B-BIOINTERFACES419205
    COMPUTERS IN BIOLOGY AND MEDICINE416229
    Frontiers in Oncology413341
    Acta Biomaterialia395585
  •  

    Frontiers in Immunology Frontiers in Immunology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/76)
  [Frontiers in Immunology] 的評論撰寫評論
作者: 今天下雨


領域: 医学
審稿時間: 3.0 month(s)
結果: 直接被接受


撰寫評論

2024-06-17 23:30:48 評論於
Why is the proportion of Chinese people so high in this publication?!
(0) 讚! | 今天下雨

作者: drliao


領域: 医学
審稿時間: 1.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-17 20:25:17 評論於
Submitted on May 4th, also received reviews from two reviewers, with similar scores to yours. Still haven't heard any news until now, not sure if there is still hope
(0) 讚! | drliao

作者: 德云小生


領域: 农林科学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-06-15 22:06:10 評論於
Your score is pretty good, steady!
(0) 讚! | 德云小生

作者: 多纳泰罗


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-11 15:04:22 評論於
FI
20240516 Submission
20240517 EA
20240527 Independent Review
20240604-20240605 Received comments from two reviewers. One 3333 and one 4444. Any more reviews?
Not yet entered Interactive Review. Display still shows "Your manuscript has been submitted successfully. You will be contacted as soon as the Reviewers’ reports are ready."
Review is ongoing.
Seeking clarification. Is this normal? Does it indicate rejection?
(1) 讚! | 多纳泰罗

作者: zhouting?


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-06 14:35:43 評論於
Don't give up
(0) 讚! | zhouting?

作者: 小蜗牛


領域: 医学
審稿時間: 7.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-31 12:38:32 評論於
The quality requirements have significantly improved, with a high rate of rejections. The reviewers are professional and take a long time in reviewing. The editors are very responsible, and hope to increase the influence of the journal
(0) 讚! | 小蜗牛

作者: 小蜗牛


領域: 医学
審稿時間: 7.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-31 12:34:27 評論於
17 Jan 2024 Interactive review forum activated.
23 May 2024 Article accepted for publication
(0) 讚! | 小蜗牛

作者: 小野寺静安


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-27 21:40:12 評論於
Please translate the following paragraph into English and Japanese, and title them as ":" and ":"
(0) 讚! | 小野寺静安

作者: 王拽拽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 10:23:48 評論於
I am also in the revision stage and have added the author. May I ask what is the current situation on your end? I have been on the manuscript reply interface for over a month
(0) 讚! | 王拽拽

作者: 123ccr


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-23 08:17:53 評論於
I will never forget the time we spent together, the laughter we shared, and the memories we created. Thank you for all the love and happiness you brought into my life
(0) 讚! | 123ccr

作者: 灵空经业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-20 21:31:59 評論於
Afterwards, what happened?
(0) 讚! | 灵空经业

作者: Joanne Leopold


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-20 15:04:32 評論於
It's really hard to write articles now
(0) 讚! | Joanne Leopold

作者: 销魂星辰


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-20 11:47:58 評論於
It's very difficult
(0) 讚! | 销魂星辰

作者: 中原冠英


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-19 22:12:04 評論於
Dengle for two months and still inactive
(0) 讚! | 中原冠英

作者: zhouting?


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-18 22:13:53 評論於
Is it not possible to provide an explanation to the editor, along with the authorship change form and signatures from all authors, given that we have already reached the final validation stage?
(0) 讚! | zhouting?

作者: 小小小钻风


領域: 医学
審稿時間: 4.0 month(s)
結果: 拒稿


撰寫評論

2024-05-18 17:48:16 評論於
This is a major taboo. The editor-in-chief of Frontiers magazine has specifically commented on this. It's best to decide on the author from the beginning and not change it later
(0) 讚! | 小小小钻风

作者: zhouting?


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-17 21:15:47 評論於
Have you ever had the experience of changing an author's work during the submission process? Is this considered a big taboo at Frontiers? What should we pay attention to?
(0) 讚! | zhouting?

作者: Joanne Leopold


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-16 20:54:13 評論於
Mendel is very unfriendly now
(0) 讚! | Joanne Leopold

作者: 宫古秋旺


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-15 21:14:41 評論於
Are you not uploading the original data?
(0) 讚! | 宫古秋旺

作者: Joanne Leopold


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-14 10:14:40 評論於
Can Mendel still send messages?
(0) 讚! | Joanne Leopold

作者: 灵空经业


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-12 20:32:11 評論於
I have been a distribution editor for over a month, but there has been no progress. I don't know what's going on
(0) 讚! | 灵空经业

作者: Sampson Whitman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-09 22:24:00 評論於
Research Focus: Immunology; Inflammation
Experience Sharing: Just got a paper accepted, took a total of 4 months. Two major revisions, and the editor made a minor revision at the end. Everyone says it's pretty ordinary, but it feels quite formal. Because of the large amount of publications, even if the impact is small, they are willing to give opportunities. This is the significance of cutting-edge research, right?
(0) 讚! | Sampson Whitman

作者: 巴蜀旭鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-29 15:50:22 評論於
It's been a month, what's going on?
(0) 讚! | 巴蜀旭鹏

作者: 巴蜀旭鹏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-27 21:08:17 評論於
It's been almost a month since I reinvested in IV after four days of withdrawal
(0) 讚! | 巴蜀旭鹏

作者: 排云夜香


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-04-21 11:14:16 評論於
Mendel submitted on Saturday, and was rejected on Monday
(0) 讚! | 排云夜香

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/76)

開始撰寫 [Frontiers in Immunology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*